Dr. Jisha John
About me
PharmD-trained healthcare researcher with experience spanning clinical pharmacy, clinical research, antimicrobial stewardship, and evidence synthesis. My work bridges patient-centered clinical practice with rigorous research methodology, including systematic reviews, meta-analysis, clinical trials, observational studies, and guideline development. I have contributed to WHO and national clinical guidelines, peer-reviewed publications, and multidisciplinary research initiatives. With a strong foundation in pharmacotherapy, infectious diseases, scientific communication, and evidence-informed decision-making, I am particularly interested in translating complex clinical evidence into meaningful insights that improve healthcare practice, policy, and patient outcomes.
Education
Christian Medical College and Hospital, Vellore - IDTRC 2020 – 2021 (1 year)
Fellowship in Antimicrobial Stewardship (FASCP),
The first fellow of the post-Pharm D Infectious Diseases fellowship program in India.
70% marks.
Annamalai University, Chidambaram - (Directorate of Distance Education) 2018-2020 (2 years)
Master of Business Administration (Hospital Management)
60% marks.
Kerala University of Health Sciences - National College of Pharmacy 2010 – 2016 (6 years)
Doctor of Pharmacy (Pharm.D.)
70% marks.
Experience (9 years)
Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Project Research Scientist III - 23rd April 2025 – 31st July 2026 (1 year, 3 months)
Technical Resources Hub, Department of Pediatrics (ACEBCH)
Reviewing the evidence for guidelines prepared by TRCs for the antibiotic guidelines for various infectious diseases.
Conducting workshops and training programs and being a faculty in various workshops in Evidence synthesis and guideline development
Drafted the introductory chapter for the DHR SOP for evidence synthesis.
Drafted the chapter “Systematic reviews and meta-analysis” in the book “The Art & Science of Writing a Scientific Paper.” by Indian Pediatrics.
Ongoing projects: - DHR Epilepsy guidelines, DHR guidelines on cough syrups.
Christian Medical College (CMC), Vellore, Tamil Nadu, India
Clinical Pharmacist and systematic reviewer Jan 2022 – April, 2025 (3 years 4 months)
Department of Infectious Diseases, Infectious Diseases Training and Research Centre (IDTRC)
Clinical Pharmacist (2022-2025)
Successfully executed an antifungal stewardship program in immunocompromised patients, in the department of hematology, Christian Medical College Vellore. The paper was presented in ID week 2022 Open Forum Infectious Diseases, Volume 9, Issue Supplement_2, December 2022, ofac492.1393, https://doi.org/10.1093/ofid/ofac492.1393
Conducted the Point Prevalence Survey of the Antibiotic consumption of the CMC, Vellore, Ranipet Campus, during September 2023, which paved the way for the full-fledged syndrome based Stewardship approach at CMC, Vellore.
Clinical Research Associate (2021- 2024)
Probiot Study - A Phase 2b study to determine the efficacy of probiotics given in peri transplant period among allogenic stem cell transplant recipients in preventing gram negative bacteremia, mortality, graft versus host disease.
Protocol writing secured the Fluid Research Grant (1.5 Lakhs), IRB meeting and DSMB meeting, Data collection and maintenance, Data cleaning.
Presented in 2025 ECCMID #03273:- Efficacy and safety of peri-transplant probiotic supplementation among allogeneic stem cell transplant recipients: A phase 2b randomised controlled trial
Fellowship in AMSP course coordinator: (2021-2025).
Mentored 4 batches of pharmacists in antimicrobial stewardship.
Secured a competitive grant for the Fellowship pharmacist’s salary.
Writing committee – World Health Organization (WHO) Echinococcus guidelines [Neglected Tropical Diseases (NTD)]
Drafted and formatted the guidelines (Published on 16 June 2025, by WHO NTD Department).
Communication Officer: - READ-It (Research, Evidence, and Dissemination Initiatives)- CMC (Christian Medical College)- Liverpool School of Tropical Medicine- Cochrane ID (CIDG) collaboration.
Collated the evidence synthesis responses of the READ-It collaboration for Covid-19. ()
Evidence synthesis:
WHO Defeating Meningitis by 2030 Roadmap - Meningitis diagnosis, treatment & care guidelines,
Brain Infection Guidelines – India
DHR-Technical Resource Centre.
India Covid Guidelines
Fellow in Antimicrobial Stewardship Nov 2020 – November 2021 (1 year)
Antimicrobial Stewardship in Medical and surgical wards
Implemented Antifungal Stewardship in department of Hematology
Believers Church Medical College Hospital, Thiruvalla, Kerala, India
Clinical Pharmacist Nov 2017 - Nov 2020 (3 years)
Department of Pharmacy
Medication management in internal medicine, respiratory medicine, and surgical departments.
NABH champion for the department of Pharmacy
Maternity Break May 2017 – Nov 2017 (6 months)
Clinical Pharmacist Dec 2016 - May 2017 (6 months)
Medication management in internal medicine, respiratory medicine, and surgical departments.
NABH champion for the department of Pharmacy
Clinical Pharmacy intern July 2016 - September 2016 (3 months)
Medication management in internal medicine, respiratory medicine, and surgical departments.
Degrees:
2. Selvarajan S, John JS, Tharyan P, Kirubakaran R, Singh B, George B, et al. Therapeutic Versus Non-Therapeutic Dose Anticoagulation in COVID-19 Infection: A Systematic Review and Meta-analysis of Randomised Controlled Trials. eJHaem. 2025;6(1): e1100.
3. Jacob A, John JS, Alexander H, George B, Selvarajan S, Samuel P, et al. A study on the effectiveness of an antifungal stewardship program in immunocompromised patients in a tertiary-care teaching hospital: The antifungal stewardship (TAFS) study. Indian Journal of Medical Microbiology. 2025 May 1; 55: 100865.
4. Guideline Recommendations: - World Health Organization – Echinococcosis (drafting member)
a. WHO guidelines for the treatment of patients with cystic echinococcosis. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.
5. WHO Guideline Recommendations: - WHO – Meningitis Roadmap Guidelines (Evidence Synthesis)
a. WHO guidelines on meningitis diagnosis, treatment and care: executive summary. Geneva: World Health Organization; 2025. https://doi.org/10.2471/B09452. Licence: CC BY-NC-SA 3.0 IGO.
6. Rupali P, Singh B, Princy NG, John JS, Kuehn R, Solomon T, et al. The India brain infections guidelines project: Global evidence for local application. Clinical Epidemiology and Global Health [Internet]. 2024 Mar 9 [cited 2024 Mar 12];0(0). Available from: https://cegh.net/article/S2213-3984(24)00056-3/fulltext
7. Korula P, Alexander H, John JSara, Kirubakaran R, Singh B, Tharyan P, Rupali P. Favipiravir for treating COVID‐19. Cochrane Database of Systematic Reviews 2024, Issue 2. Art. No.: CD015219. DOI: 10.1002/14651858.CD015219.pub2. Accessed 22 February 2024.
8. Alexander H, Gunasekaran K, John JS, Zacchaeus NGP, Samuel P, Jasmine S, et al. Evaluation of Remdesivir to the outcomes of hospitalized patients with COVID-19 infection in a tertiary-care hospital in southern India. The Journal of Infection in Developing Countries. 2023 Mar 31;17(03):304–10.
9. Korula P, Alexander H, John JS, Kirubakaran R, Singh B, Tharyan P, et al. Favipiravir for treating COVID‐19. Cochrane Database of Systematic Reviews [Internet]. 2022 [cited 2022 Aug 10]; (5). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015219/full
10. Guideline recommendations: - India Covid Guidelines (2021-2022)
a. Covid Management Guidelines India Group - Anticoagulation Working Group. Prophylactic Vs Therapeutic dose anticoagulation. Covid Guidelines India; Published online on August 08th, 2022; URL: https://indiacovidguidelines.org/therapeutic-dose-vs-nontherapeutic-dose-of-thromboprophylaxis/(accessed on 10/08/2022)
b. Covid Management Guidelines India Group – Antiviral working Group – Azithromycin. Covid Guidelines India; Published online on September 27th, 2021; URL: https://indiacovidguidelines.org/azithromycin/
c. Covid Management Guidelines India Group - Anti-viral Working Group. Favipiravir. Covid Guidelines India; Published online on July 19, 2021; URL: https://indiacovidguidelines.org/favipiravir/